• April 13. Valuable patient support: Looking backwards and forwards to learn from what has worked and what hasn’t.
  
  
• May 11. The complex disease patient journey: How patient self-care drives adherence and outcomes in diabetes, heart failure and Crohn’s Disease.
  
  
• June 8. The role of data: Patient reported, diagnostic, HIE and other data sources. Using the data to change patient behavior, measure, learn and report as necessary to governments and payers.
  
  
• July 13. Effective patient support globally: Help each geography provide effective patient engagement and adherence support building on existing assets
  
  

Background:

The last 50 years have been about volume-based healthcare. Reimbursement systems globally rewarded more diagnostics, more therapies, more healthcare. Biopharma and medtech reacted to this reality with sales and marketing based on maximizing volume of patient and physician communications.

The future is value-based healthcare. This requires a new offering from biopharma and medtech. Instead of one-off diagnostics and therapies, the future is about total disease solutions, integrating diagnostics, therapies and patient support. This will require sales and marketing communications with patients and physicians which increase the value of the solution vs. creating extraneous noise.

Even the most exceptional therapy with the most robust data must operate in a real world environment of how the patient takes the therapy, manages the disease and other behavioral factors. Thus, the product itself is only part of the equation.